Catalyst Pharmaceuticals Inc - Company Profile
Powered by 
All the sales intelligence you need on Catalyst Pharmaceuticals Inc in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Catalyst Pharmaceuticals Inc fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Catalyst Pharmaceuticals Inc.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
View up-to-date information on Catalyst Pharmaceuticals Inc patents, including inventor and filing insights.
Patent Trends
| Publication Identifier | Document Type | Title | Classification-CPC | Publication Date |
|---|---|---|---|---|
| WO2023023463A1 | Application | Method for treating botulinum toxin poisoning | A61K31/44; A61P39/02; Y02A50/30 | February 23, 2023 |
| WO2021026071A9 | Search Report | Method for treating sexual dysfunction | A61P25/16; A61K31/44; A61P15/00 | March 11, 2021 |
| WO2021026071A1 | Application | Method for treating sexual dysfunction | A61P25/16; A61P15/00; A61K31/44 | February 11, 2021 |
| EP2806867A4 | Search Report | Verfahren zur behandlung von tourette-syndrom mit gaba-aminotransferaseinaktivatoren | A61K31/131; A61K31/13; A61K31/197; A61P25/00; A61K31/195 | September 02, 2015 |
| US20150196522A1 | Application | Methods of using (1S,3S)-3-amino-4-difluoromethylenyl-1-cyclopentanoic acid | A61K31/195; A61K31/197; A61K31/205; A61P25/00; A61P25/06; A61P25/28; A61P25/30; A61P29/00; A61P3/04 | July 16, 2015 |
Top Inventors by Filings (Count by publication)
| Name | Count |
|---|
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer